Delaware | 333-274434 | 93-3205861 | ||||||||||||
(State or other jurisdiction
of incorporation)
|
(Commission File Number) | (IRS Employer Identification No.) |
(Address of principal executive offices, including zip code) | ||||||||
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Common Stock, par value $0.01 per share | FREY |
The New York Stock Exchange | ||||||||||||
Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 | FREY WS | The New York Stock Exchange |
Exhibit No. | Description | |||||||
99.1 | ||||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
FREYR BATTERY, INC. | ||||||||
Date: November 6, 2024 |
By: | /s/ Joseph Evan Calio | ||||||
Name: | Joseph Evan Calio | |||||||
Title: | Chief Financial Officer |
September 30, 2024 |
December 31, 2023 |
|||||||||||||
ASSETS | ||||||||||||||
Current assets: | ||||||||||||||
Cash and cash equivalents | $ | 181,851 | $ | 253,339 | ||||||||||
Restricted cash | 2,202 | 22,403 | ||||||||||||
Prepaid assets | 2,838 | 2,168 | ||||||||||||
Other current assets | 12,583 | 34,044 | ||||||||||||
Total current assets | 199,474 | 311,954 | ||||||||||||
Property and equipment, net | 368,342 | 366,357 | ||||||||||||
Intangible assets, net | 2,700 | 2,813 | ||||||||||||
Long-term investments | 21,819 | 22,303 | ||||||||||||
Right-of-use asset under operating leases | 22,640 | 24,476 | ||||||||||||
Other long-term assets | 10 | 4,282 | ||||||||||||
Total assets | $ | 614,985 | $ | 732,185 | ||||||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||
Current liabilities: | ||||||||||||||
Accounts payable | $ | 10,080 | $ | 18,113 | ||||||||||
Accrued liabilities and other | 21,254 | 30,790 | ||||||||||||
Share-based compensation liability | 19 | 281 | ||||||||||||
Total current liabilities | 31,353 | 49,184 | ||||||||||||
Warrant liability | 721 | 2,025 | ||||||||||||
Operating lease liability | 16,775 | 18,816 | ||||||||||||
Other long-term liabilities | 27,446 | 27,444 | ||||||||||||
Total liabilities | 76,295 | 97,469 | ||||||||||||
Commitments and contingencies | ||||||||||||||
Stockholders’ equity: | ||||||||||||||
Preferred stock, $0.01 par value, 10,000 shares authorized, none issued and outstanding as of both September 30, 2024 and December 31, 2023 |
— | — | ||||||||||||
Common stock, $0.01 par value, 355,000 shares authorized as of both September 30, 2024 and December 31, 2023; 140,490 issued and outstanding as of September 30, 2024; and 139,705 issued and outstanding as of December 31, 2023 |
1,405 | 1,397 | ||||||||||||
Additional paid-in capital | 929,324 | 925,623 | ||||||||||||
Accumulated other comprehensive loss | (34,035) | (18,826) | ||||||||||||
Accumulated deficit | (358,004) | (274,999) | ||||||||||||
Total stockholders' equity | 538,690 | 633,195 | ||||||||||||
Non-controlling interests | — | 1,521 | ||||||||||||
Total equity | 538,690 | 634,716 | ||||||||||||
Total liabilities and equity | $ | 614,985 | $ | 732,185 |
Three months ended September 30, |
Nine months ended September 30, |
|||||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||||||||||||||||
Operating expenses: | ||||||||||||||||||||||||||
General and administrative | $ | 18,515 | $ | 27,772 | $ | 61,386 | $ | 85,405 | ||||||||||||||||||
Research and development | 8,616 | 7,086 | 30,854 | 18,295 | ||||||||||||||||||||||
Restructuring charge | 4,507 | — | 4,644 | — | ||||||||||||||||||||||
Share of net loss of equity method investee | 150 | 153 | 484 | 208 | ||||||||||||||||||||||
Total operating expenses | 31,788 | 35,011 | 97,368 | 103,908 | ||||||||||||||||||||||
Loss from operations | (31,788) | (35,011) | (97,368) | (103,908) | ||||||||||||||||||||||
Other income (expense): | ||||||||||||||||||||||||||
Warrant liability fair value adjustment | 1,096 | 24,399 | 1,294 | 23,248 | ||||||||||||||||||||||
Interest income, net | 1,074 | 1,284 | 3,627 | 6,042 | ||||||||||||||||||||||
Foreign currency transaction (loss) gain | (110) | (3,213) | 1,245 | 20,546 | ||||||||||||||||||||||
Other income, net | 2,172 | 2,537 | 7,806 | 6,103 | ||||||||||||||||||||||
Total other income | 4,232 | 25,007 | 13,972 | 55,939 | ||||||||||||||||||||||
Loss before income taxes | (27,556) | (10,004) | (83,396) | (47,969) | ||||||||||||||||||||||
Income tax expense | — | — | (11) | (341) | ||||||||||||||||||||||
Net loss | (27,556) | (10,004) | (83,407) | (48,310) | ||||||||||||||||||||||
Net loss attributable to non-controlling interests | 81 | 219 | 402 | 517 | ||||||||||||||||||||||
Net loss attributable to stockholders | $ | (27,475) | $ | (9,785) | $ | (83,005) | $ | (47,793) | ||||||||||||||||||
Weighted average shares outstanding - basic and diluted | 140,490 | 139,705 | 140,102 | 139,705 | ||||||||||||||||||||||
Net loss per share attributable to stockholders - basic and diluted | $ | (0.20) | $ | (0.07) | $ | (0.59) | $ | (0.34) | ||||||||||||||||||
Other comprehensive (loss) income: | ||||||||||||||||||||||||||
Net loss | $ | (27,556) | $ | (10,004) | $ | (83,407) | $ | (48,310) | ||||||||||||||||||
Foreign currency translation adjustments | 5,973 | 6,134 | (15,209) | (48,009) | ||||||||||||||||||||||
Total comprehensive loss | $ | (21,583) | $ | (3,870) | $ | (98,616) | $ | (96,319) | ||||||||||||||||||
Comprehensive loss attributable to non-controlling interests | 81 | 219 | 402 | 517 | ||||||||||||||||||||||
Comprehensive loss attributable to stockholders | $ | (21,502) | $ | (3,651) | $ | (98,214) | $ | (95,802) | ||||||||||||||||||
Nine months ended September 30, |
||||||||||||||
2024 | 2023 | |||||||||||||
Cash flows from operating activities: | ||||||||||||||
Net loss | $ | (83,407) | $ | (48,310) | ||||||||||
Adjustments to reconcile net loss to cash used in operating activities: | ||||||||||||||
Share-based compensation expense | 6,449 | 7,859 | ||||||||||||
Depreciation and amortization | 7,028 | 1,922 | ||||||||||||
Reduction in the carrying amount of right-of-use assets | 1,282 | 1,005 | ||||||||||||
Warrant liability fair value adjustment | (1,294) | (23,248) | ||||||||||||
Share of net loss of equity method investee | 484 | 208 | ||||||||||||
Foreign currency transaction net unrealized gain | (1,075) | (19,346) | ||||||||||||
Other | — | (929) | ||||||||||||
Changes in assets and liabilities: | ||||||||||||||
Prepaid assets and other current assets | 13 | 1,672 | ||||||||||||
Accounts payable, accrued liabilities and other | (429) | 28,401 | ||||||||||||
Operating lease liability | (1,626) | (3,212) | ||||||||||||
Net cash used in operating activities | (72,575) | (53,978) | ||||||||||||
Cash flows from investing activities: | ||||||||||||||
Proceeds from the return of property and equipment deposits | 22,735 | — | ||||||||||||
Proceeds from property related grants | — | 3,500 | ||||||||||||
Purchases of property and equipment | (34,683) | (168,811) | ||||||||||||
Investments in equity method investee | — | (1,655) | ||||||||||||
Purchases of other long-term assets | — | (1,000) | ||||||||||||
Net cash used in investing activities | (11,948) | (167,966) | ||||||||||||
Cash flows from financing activities: | ||||||||||||||
Payment for non-controlling interest | (4,130) | — | ||||||||||||
Net cash used in financing activities | (4,130) | — | ||||||||||||
Effect of changes in foreign exchange rates on cash, cash equivalents, and restricted cash | (3,036) | (13,240) | ||||||||||||
Net decrease in cash, cash equivalents, and restricted cash | (91,689) | (235,184) | ||||||||||||
Cash, cash equivalents, and restricted cash at beginning of period | 275,742 | 563,045 | ||||||||||||
Cash, cash equivalents, and restricted cash at end of period | $ | 184,053 | $ | 327,861 | ||||||||||
Supplementary disclosure for non-cash activities: | ||||||||||||||
Accrued purchases of property and equipment | $ | 6,133 | $ | 11,187 | ||||||||||
Reconciliation to condensed consolidated balance sheets: | ||||||||||||||
Cash and cash equivalents | $ | 181,851 | $ | 299,419 | ||||||||||
Restricted cash | 2,202 | 28,442 | ||||||||||||
Cash, cash equivalents, and restricted cash | $ | 184,053 | $ | 327,861 |